靜脈注射解決方案市場,按類型、營養素、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測
市場調查報告書
商品編碼
1351416

靜脈注射解決方案市場,按類型、營養素、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Intravenous Solutions Market, By Type, By Nutrients, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

出版日期: | 出版商: AnalystView Market Insights | 英文 307 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022年靜脈注射解決方案市場規模為1,191,011萬美元,2023年至2030年年複合成長率為8.11%。

在醫療保健領域,靜脈輸液在各種醫療環境中發揮關鍵作用,包括醫院、診所和急診室。它們的重要性在於它們能夠維持和調節適當的液體平衡,支持關鍵的生理過程,並確保治療化合物和營養物質的有效分配。

靜脈解決方案市場 - 市場動態:

  • 神經系統疾病、胃腸道疾病和癌症等疾病的發生率增加
  • 靜脈注射液市場的強勁擴張可歸因於各種疾病的盛行率激增,包括胃腸道疾病、神經系統疾病和癌症。這些情況通常需要使用靜脈治療來有效給藥和補充水分。因此,靜脈注射液的需求顯著增加,靜脈注射液是病人的重要生命線。這種需求的增加不僅改善了患者護理,還推動了市場成長,因為醫療保健專業人員越來越依賴這些解決方案來管理各種醫療狀況。
  • 根據全球健康數據,世界衛生組織(WHO)報告稱,2018年全球癌症發病率超過1810萬例,預計到2034年這一數位將激增至2200萬例。此外,世界衛生組織的統計數據表明,胃腸道疾病影響癌症患者的健康。美國估計有 6000 至 7000 萬人。這種流行凸顯了對腸外營養解決方案(包括葡萄糖、磷脂質、麩醯胺酸和胺基酸)的日益成長的需求,以滿足患者的醫療保健需求。

靜脈解決方案市場 - 主要見解:

  • 根據我們的研究分析師提供的見解,全球靜脈注射解決方案市場預計將經歷強勁的年度成長,在 2023 年至 2030 年的預測期內,預計年複合成長率 (CAGR) 約為 7.9%。
  • 該行業的成長軌跡受到重要因素的支撐,主要是神經系統疾病、胃腸道疾病和癌症等各種醫療狀況的盛行率不斷上升。
  • 就產品分類而言,全腸外營養領域成為 2022 年市佔率的主要貢獻者。
  • 此外,在考慮營養成分細分時,單劑量胺基酸類別在 2022 年表現出了其突出地位。
  • 從地理位置來看,北美將在 2022 年成為該市場的主要創收區域。

靜脈注射解決方案市場-細分分析:

  • 全球靜脈注射解決方案市場呈現三個關鍵維度的細分:類型、營養和地理區域。
  • 就類型分類而言,市場可分為全腸外營養和周邊腸外營養。全腸外營養涉及繞過消化系統將營養液直接輸送到血液中。這些解決方案的管理通常是根據個人的體重、年齡、身高和特定醫療狀況等因素量身定做的。這些解決方案廣泛用於胃腸道疾病的治療、燒傷的治療、腸道綜合症的治療、支持接受化療的患者以及促進術後復健。

靜脈解決方案市場-競爭格局:

企業採用多種策略將產品推向市場,利用企業網站、電子商務平台、零售合作夥伴、經銷商和直接面對消費者的方式等多種管道。產品製造商之間的競爭集中在各種因素,包括定價、性能、製造流程、技術進步、品牌聲譽和產品可用性。為了鞏固市場佔有率並擴大佔有率,公司採用了一系列策略。其中包括推出新產品、擴大分銷網路、大力投資研發、進行併購。

例如,2022 年 2 月,貝朗醫療獲得美國食品藥物管理局的批准,在佛羅裡達州代托納比奇新建的靜脈注射鹽溶液生產工廠開始運作。在 2021 年 9 月的另一個例子中,B. Braun Medical Inc. 推出了 CARESAFE IV Administration Sets,具有可選的 AirStop 組件,增強了其產品組合。

目錄

第 1 章:靜脈注射解決方案市場概述

  • 研究範圍
  • 市場預估年份

第 2 章:執行摘要

  • 市場片段
    • 按類型分類的靜脈注射解決方案市場片段
    • 靜脈注射解決方案市場片段(按營養素)
    • 按國家/地區分類的靜脈注射解決方案市場片段
    • 按地區分類的靜脈注射解決方案市場片段
  • 競爭洞察

第 3 章:靜脈注射解決方案主要市場趨勢

  • 靜脈注射解決方案市場促進因素
    • 市場促進因素的影響分析
  • 靜脈注射解決方案市場限制
    • 市場限制影響分析
  • 靜脈注射解決方案市場機會
  • 靜脈注射解決方案市場未來趨勢

第 4 章:靜脈注射解決方案產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章:靜脈解決方案市場:COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長部分
    • 最鬆散的部分
    • 邊際損失部分

第 6 章:靜脈解決方案市場格局

  • 2022 年靜脈解決方案市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既定玩家分析
    • 新興玩家分析

第 7 章:靜脈解決方案市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 全腸外營養
    • 週邊腸外營養

第 8 章:靜脈注射解決方案市場 - 按營養成分

  • 概述
    • 按營養成分分類的細分市場佔有率分析
    • 單劑量氨基酸溶液
    • 碳水化合物
    • 腸外脂質乳劑
    • 維生素和礦物質
    • 其他

第 9 章:靜脈注射解決方案市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美靜脈注射解決方案主要製造商
    • 北美市場規模和預測(按國家)
    • 北美市場規模和預測(按類型)
    • 北美市場規模與預測(按營養成分)
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲靜脈注射解決方案主要製造商
    • 歐洲市場規模和預測(按國家)
    • 歐洲市場規模與預測(按類型)
    • 歐洲市場規模與預測(按營養成分)
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區靜脈注射解決方案主要製造商
    • 亞太地區市場規模與預測(按國家)
    • 亞太地區市場規模與預測(按類型)
    • 亞太地區市場規模與預測(依營養成分)
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲靜脈注射解決方案主要製造商
    • 拉丁美洲市場規模與預測(按國家)
    • 拉丁美洲市場規模與預測(按類型)
    • 拉丁美洲市場規模與預測(按營養成分)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲靜脈注射解決方案主要製造商
    • 中東和非洲市場規模及預測(按國家)
    • 中東和非洲市場規模及預測(按類型)
    • 中東和非洲市場規模及預測(按營養成分)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 10 章:主要供應商分析 - 靜脈注射解決方案產業

  • 競爭儀表板
  • 公司簡介
    • Vifor Pharma Group
    • Vetter Pharma-Fertigung GmbH & Co. KG
    • Terumo Corporation
    • Smiths Medical (a division of Smiths Group plc)
    • Sippex Pharmaceuticals Pvt. Ltd.
    • Sichuan Kelun Pharmaceutical Co., Ltd.
    • Otsuka Pharmaceutical Co., Ltd.
    • JW Pharmaceutical Corporation
    • ICU Medical, Inc.
    • Hospira (now part of Pfizer Inc.)
    • Grifols SA
    • Fresenius SE & Co. KGaA
    • Baxter International Inc.
    • B. Braun Melsungen AG
    • Amanta Healthcare Ltd.

第 11 章:360 度分析師視角

第 12 章:附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV1664

REPORT HIGHLIGHT

Intravenous Solutions Market size was valued at USD 11,910.11 Million in 2022, expanding at a CAGR of 8.11% from 2023 to 2030.

Intravenous infusion solutions, commonly referred to as IV infusions, are sterile liquid formulations administered directly into a patient's bloodstream through a needle or catheter. These specialized solutions are meticulously crafted to provide essential hydration, replenish vital electrolytes, and facilitate the delivery of medications or essential nutrients when a patient cannot ingest them orally.

Within the realm of healthcare, IV infusions play a pivotal role across various medical settings, encompassing hospitals, medical clinics, and emergency care units. Their significance lies in their ability to uphold and regulate proper fluid balance, support crucial physiological processes, and ensure the efficient dispensation of therapeutic compounds and nutrients.

Intravenous Solutions Market - Market Dynamics:

  • Increasing incidence of diseases like neurological conditions, gastrointestinal disorders, and cancer
  • The robust expansion of the Intravenous Solutions market can be attributed to the surging prevalence of various medical conditions, including gastrointestinal disorders, neurological ailments, and cancer. These conditions often necessitate the use of intravenous therapy for effective medication administration and hydration. Consequently, there has been a notable escalation in the demand for intravenous solutions, which serve as a crucial lifeline for patients. This heightened demand not only improves patient care but also fuels market growth, as healthcare professionals increasingly rely on these solutions to manage a wide spectrum of medical conditions.
  • In line with global health data, the World Health Organization (WHO) reported that the global incidence of cancer exceeded 18.1 million cases in 2018, and this figure is projected to surge to 22.0 million by 2034. Furthermore, WHO statistics indicate that gastrointestinal diseases affect an estimated 60 to 70 million individuals in the United States. This prevalence underscores the growing need for parenteral nutritional solutions, encompassing glucose, phospholipids, glutamine, and amino acids, to address the healthcare requirements of patients.

Intravenous Solutions Market - Key Insights:

  • According to insights provided by our research analysts, the global Intravenous Solutions market is anticipated to experience robust annual growth, with a projected Compound Annual Growth Rate (CAGR) of approximately 7.9% during the forecast period spanning from 2023 to 2030.
  • This industry's growth trajectory is underpinned by significant factors, primarily the escalating prevalence of various medical conditions such as neurological disorders, gastrointestinal ailments, and cancer.
  • In terms of product categorization, the segment dedicated to total parenteral nutrition emerged as the leading contributor to market share for the year 2022.
  • Furthermore, when considering nutrient segmentation, the single-dose amino acid category demonstrated its prominence in 2022.
  • Geographically, North America emerged as the primary revenue-generating region for the market in the year 2022.

Intravenous Solutions Market- Segmentation Analysis:

  • The worldwide Intravenous Solutions Market exhibits segmentation across three key dimensions: Type, Nutrient, and Geographic Region.
  • In terms of Type classification, the market can be categorized into Total Parenteral Nutrition and Peripheral Parenteral Nutrition. Total Parenteral Nutrition involves the direct delivery of nourishing fluids into the bloodstream, bypassing the digestive system. The administration of these solutions is typically customized based on factors such as an individual's weight, age, height, and specific medical condition. These solutions find extensive use in the management of gastrointestinal disorders, treatment of burn injuries, addressing bowel syndromes, supporting patients undergoing chemotherapy, and facilitating post-surgical recovery.

Intravenous Solutions Market- Competitive Landscape:

Businesses employ a diverse array of strategies to bring their products to market, leveraging multiple channels like corporate websites, e-commerce platforms, retail partners, distributors, and direct-to-consumer approaches. Competition among product manufacturers centers on various factors encompassing pricing, performance, manufacturing processes, technological advancements, brand reputation, and product availability. To fortify their market presence and broaden their share, companies employ a range of tactics. These include the introduction of new products, the expansion of distribution networks, significant investments in research and development, and engaging in mergers and acquisitions.

For example, in February 2022, B. Braun Medical secured approval from the US Food and Drug Administration to initiate operations at their newly established IV saline solution production facility in Daytona Beach, Florida. In a separate instance from September 2021, B. Braun Medical Inc. unveiled CARESAFE IV Administration Sets, featuring an optional AirStop component, enhancing their product portfolio.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INTRAVENOUS SOLUTIONS MARKET KEY PLAYERS

  • Vifor Pharma Group
  • Vetter Pharma-Fertigung GmbH & Co. KG
  • Terumo Corporation
  • Smiths Medical (a division of Smiths Group plc)
  • Sippex Pharmaceuticals Pvt. Ltd.
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • Otsuka Pharmaceutical Co., Ltd.
  • JW Pharmaceutical Corporation
  • ICU Medical, Inc.
  • Hospira (now part of Pfizer Inc.)
  • Grifols S.A.
  • Fresenius SE & Co. KGaA
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Amanta Healthcare Ltd.

GLOBAL INTRAVENOUS SOLUTIONS MARKET, BY TYPE

  • Total Parenteral Nutrition
  • Peripheral Parenteral Nutrition

GLOBAL INTRAVENOUS SOLUTIONS MARKET, BY NUTRIENT

  • Single-Dose Amino Acid Solutions
  • Carbohydrates
  • Parenteral Lipid Emulsion
  • Vitamins & Minerals
  • Others

GLOBAL INTRAVENOUS SOLUTIONS MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Intravenous Solutions Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Intravenous Solutions Market Snippet by Type
    • 2.1.2. Intravenous Solutions Market Snippet by Nutrient
    • 2.1.3. Intravenous Solutions Market Snippet by Country
    • 2.1.4. Intravenous Solutions Market Snippet by Region
  • 2.2. Competitive Insights

3. Intravenous Solutions Key Market Trends

  • 3.1. Intravenous Solutions Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Intravenous Solutions Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Intravenous Solutions Market Opportunities
  • 3.4. Intravenous Solutions Market Future Trends

4. Intravenous Solutions Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Intravenous Solutions Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Intravenous Solutions Market Landscape

  • 6.1. Intravenous Solutions Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Intravenous Solutions Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
    • 7.1.2. Total Parenteral Nutrition
    • 7.1.3. Peripheral Parenteral Nutrition

8. Intravenous Solutions Market - By Nutrient

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Nutrient, 2022 & 2030 (%)
    • 8.1.2. Single-Dose Amino Acid Solutions
    • 8.1.3. Carbohydrates
    • 8.1.4. Parenteral Lipid Emulsion
    • 8.1.5. Vitamins & Minerals
    • 8.1.6. Others

9. Intravenous Solutions Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Intravenous Solutions Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Intravenous Solutions Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Intravenous Solutions Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Intravenous Solutions Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Intravenous Solutions Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Intravenous Solutions Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Vifor Pharma Group
    • 10.2.2. Vetter Pharma-Fertigung GmbH & Co. KG
    • 10.2.3. Terumo Corporation
    • 10.2.4. Smiths Medical (a division of Smiths Group plc)
    • 10.2.5. Sippex Pharmaceuticals Pvt. Ltd.
    • 10.2.6. Sichuan Kelun Pharmaceutical Co., Ltd.
    • 10.2.7. Otsuka Pharmaceutical Co., Ltd.
    • 10.2.8. JW Pharmaceutical Corporation
    • 10.2.9. ICU Medical, Inc.
    • 10.2.10. Hospira (now part of Pfizer Inc.)
    • 10.2.11. Grifols S.A.
    • 10.2.12. Fresenius SE & Co. KGaA
    • 10.2.13. Baxter International Inc.
    • 10.2.14. B. Braun Melsungen AG
    • 10.2.15. Amanta Healthcare Ltd.

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Intravenous Solutions Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Intravenous Solutions Market, by Type 2018-2030 (USD Million)
  • TABLE Intravenous Solutions Market: Nutrient Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Nutrient
  • TABLE Global Intravenous Solutions Market, by Nutrient 2018-2030 (USD Million)
  • TABLE Intravenous Solutions Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Intravenous Solutions Market, by Region 2018-2030 (USD Million)
  • TABLE North America Intravenous Solutions Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Intravenous Solutions Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Intravenous Solutions Market, by Nutrient, 2018-2030 (USD Million)
  • TABLE Europe Intravenous Solutions Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Intravenous Solutions Market, by Type, 2018-2030 (USD Million)
  • TABLE Europe Intravenous Solutions Market, by Nutrient, 2018-2030 (USD Million)
  • TABLE Asia Pacific Intravenous Solutions Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Intravenous Solutions Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Intravenous Solutions Market, by Nutrient, 2018-2030 (USD Million)
  • TABLE Latin America Intravenous Solutions Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Intravenous Solutions Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Intravenous Solutions Market, by Nutrient, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Intravenous Solutions Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Intravenous Solutions Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Intravenous Solutions Market, by Nutrient, 2018-2030 (USD Million)